Dubai: Mediclinic Middle East, part of Mediclinic International, a private hospital group with three operating platforms in Southern Africa, Switzerland and the United Arab Emirates, and a 29.9% shareholding in Spire Healthcare in the UK, announces the acquisition of a minority stake in Bourn Hall International MENA Limited, the holding company for the Bourn Hall Fertility Centre in the UAE, a pioneering fertility centre which was brought to the Middle East in 2010 by specialist private equity firm TVM Capital Healthcare.
The acquisition lays the foundation for a partnership focused on a long-term MENA-focused expansion in the field of Assisted Reproduction. In a first step, Bourn Hall Fertility Centre will take over operations of Mediclinic Middle East’s existing IVF clinic located at Mediclinic Al Ain Hospital, and operate it under the Bourn Hall umbrella, as Bourn Hall International MENA Ltd. will continue to operate and manage its IVF business independently and under its existing brand.
Today, Bourn Hall Fertility Centre in Dubai is the only fertility center in the Middle East to be accredited by JCI, the oldest and largest standards-setting and accrediting body in health care in the United States. Bourn Hall’s UK founder, Professor Robert Edwards, invented the IVF concept over forty years ago, in 1978, and was subsequently awarded the Nobel Prize in medicine in 2010.
Hoda Abou-Jamra, CEO of Bourn Hall International and Founding Partner of TVM Capital Healthcare, commented: “We are very pleased to have found such a reputable strategic partner to further grow Bourn Hall International MENA Ltd. within the UAE and the MENA region which present significant opportunities for the growth of IVF clinics. A rise of infertility levels caused by genetics and lifestyle factors, is not matched by a sufficient supply of high-quality, state-of-the-art IVF providers.”
David Hadley, Chief Executive Officer at Mediclinic Middle East, commented: “We are delighted to be working with Bourn Hall International MENA Limited, a brand synonymous with IVF, to expand Mediclinic Middle East’s presence in this growing and important market. Their reputation for trusted expertise and quality outcomes matches our own, as does their ethical approach to healthcare, and they will bring a wealth of additional knowledge and experience to the IVF centre we currently operate at Mediclinic Al Ain Hospital and the services we plan to add across the region in the future.”
-End-
About Mediclinic Middle East
Mediclinic Middle East is part of Mediclinic International, a private hospital group with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates, and a 29.9% shareholding in Spire Healthcare, a UK-based healthcare group with 38 hospitals.
Mediclinic Middle East operates seven hospitals and over 20 clinics with more than 900 inpatient beds in the United Arab Emirates.
Mediclinic puts science at the heart of its care approach, focusing on providing the best possible facilities with international-standard technology, backed-up by sound medical expertise and the empathy of its nursing staff.
For further information about Mediclinic Middle East and its facilities visit www.mediclinic.ae.
About TVM Capital Healthcare
TVM Capital Healthcare is a specialist private equity firm that invests in healthcare companies that address major unmet medical needs. The firm connects innovative companies with the local demand in emerging economies and invests directly in businesses operating across Emerging Asia and the MENAT Region. Investment risk is mitigated by strong involvement in strategy development and value creation, including hands-on operations, in special cases, through deploying healthcare experts from TVM Operations Group to support management teams meet the challenges of growth.
TVM Capital Healthcare is headquartered in Dubai with operations in Singapore and deep connections in the centers of medical innovation worldwide, such as San Francisco, Boston, Toronto, London, or Munich. The firm is part of the international TVM Capital network, an affiliation of venture capital and private equity firms. Other network members operate out of Munich, Germany, and Montreal, Canada. The first TVM Capital company was founded in Germany in 1984.
About Bourn Hall International MENA Limited
Bourn Hall International MENA Limited operates a world-class branded in vitro fertilization (IVF) reference centre in Dubai and is majority-owned by TVM Capital Healthcare. Bourn Hall founders invented IVF in 1978 with the first successful birth of a child, Louise Brown, conceived through an IVF procedure or “test tube baby”. Since then, ‘Bourn Hall’ has become synonymous with IVF and most of what is today the standard treatment protocol for IVF procedures was pioneered and established by Bourn Hall. As the ultimate testament of Bourn Hall’s world-leading expertise, its founder, Professor Robert Edwards, was awarded the Nobel Prize in medicine in 2010 for the invention of IVF.
The Bourn Hall International MENA Limited IVF centre in Dubai, was the first stand-alone IVF clinic to be JCI accredited in the region. JCI accreditation is considered the gold standard in global health care. JCI consultants are the most skilled and experienced in the industry. The centre provides several state-of-the-art operating theatres as well as the regions first and largest clean-room laboratory, and hosts a multinational team of Doctors, all assigned specialists in the field of Assisted Reproduction.
Media Contact
Brunswick Gulf on behalf of TVM Capital Healthcare
Tasha Young
+971 4 560 9642
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
